|
Promega and Celsis In Vitro Technologies to Offer More Reliable Solutions for ADME/Tox Testing in Primary Hepatocytes (Centre Daily Times)
Promega Corp. and Baltimore, Md.-based Celsis In Vitro Technologies (Celsis IVT) will take the trial and guess work out of ADME/Tox testing in primary hepatocytes. Promega will co-market their bioluminescent ADME-Tox assays with Celsis’ extensive line of high quality cryopreserved plateable hepatocytes. Under the agreement, Celsis will pre-qualify lots of cryoplateable hepatocytes for use with ...
(Feb 9, 2009)
QIAGEN Reports Strong Fourth Quarter and Fiscal 2008 Results (GlobeNewswire via Yahoo! Finance)
VENLO, The Netherlands, Feb. 9, 2009 -- QIAGEN N.V. today announced preliminary unaudited results of operations for the fourth quarter and the fiscal year ended December 31, 2008.
(Feb 9, 2009)
ABRF Study Explores microRNA Array Platforms (GenomeWeb News)
MEMPHIS, Tenn. – Several research groups under the auspices of the Association of Biomolecular Resource Facilities are comparing how different microarray platforms stack up when it comes to microRNA analysis.
(Feb 9, 2009)
BioInformatics, LLC, A Recognized Sponsor of First Annual Consumer Genetics Show in Boston, June 9-11, 2009 (PR Newswire via Yahoo! Finance)
BioInformatics, LLC -- the leading market research and consulting firm serving the life science industry -- will be a recognized sponsor of the First Annual Consumer Genetics Show in Boston, MA at the Hynes Convention Center on June 9-11, 2009.
(Feb 9, 2009)
DJ HUGIN NEWS/QIAGEN Reports Strong Fourth Quarter -4- (Financial.de)
Corporate news announcement processed and transmitted by Hugin AS.
(Feb 9, 2009)
DJ HUGIN NEWS/QIAGEN Reports Strong Fourth Quarter -3- (Financial.de)
Corporate news announcement processed and transmitted by Hugin AS.
(Feb 9, 2009)
09.02.2009 - DJ HUGIN NEWS/QIAGEN Reports Strong Fourth Quarter and Fiscal 2008 Results (4investors)
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. =----------------------------- =-------------
(Feb 9, 2009)
09.02.2009 - DJ HUGIN NEWS/QIAGEN Reports Strong Fourth Quarter and Fiscal 2008 Results (4investors)
Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. =----------------------------- =-------------
(Feb 9, 2009)
Camouflaging of viral DNA could be crucial step in progression of cancers (EurekAlert!)
( Cold Spring Harbor Laboratory ) 15 percent of cancers can be linked to a viral infection. However, the biological changes that cause some asymptomatic carriers of a virus to develop malignancies are not well understood. In a study published online in Genome Research, scientists mapped a chemical modification of DNA in Epstein-Barr, human papilloma and hepatitis B viruses and found that the ...
(Feb 9, 2009)
First genome-wide expression analysis yields better understanding of how leukemia develops (EurekAlert!)
( University of Rochester Medical Center ) In a collaborative study published Feb. 9, 2009, in the Proceedings of the National Academy of Sciences, scientists performed a genome-wide expression analysis comparing highly enriched normal blood stem cells and leukemic stem cells, and identified several new pathways that have a key role in cancer development.
(Feb 9, 2009)
Go West? Top Mass. Life-Sci Leaders Pitch Bay State's Bounty to West Coast's Drought (GenomeWeb News)
Visiting the nation's top life-sciences cluster as part of a four-day, three-state West Coast trade trip, Massachusetts' top life-sci official last week joined the state's governor and other state leaders in rolling out a campaign to recruit bioscience and other tech businesses to the Bay State.
(Feb 9, 2009)
New understanding of how leukemia develops (News-Medical-Net)
In a collaborative study published Feb. 9, 2009, in the Proceedings of the National Academy of Sciences (PNAS), scientists performed a genome-wide expression analysis comparing highly enriched normal blood stem cells and leukemic stem cells, and identified several new pathways that have a key role in cancer development.
(Feb 10, 2009)
Myriad Genetics, Inc. (MYGN): Zacks Rank Buy (Zacks.com via Yahoo! Finance)
The genetic testing company just reported excellent results and estimates are surging.
(Feb 10, 2009)
C-DAC to organize technical meet on 'onco biomed-informatics' in B'lore on Feb 11 (PharmaBiz)
Centre for Development of Advanced Computing (C-DAC) of Pune, in association with Cancer Biomedical Informatics Grid (caBIG) of USA, is organizing a one-and-half-day technical event titled 'Meet on Cancer Biomedical Informatics Grid: Cooperation for Cancer Research' on February 11 and 12, 2009.
(Feb 10, 2009)
CombiMatrix Will Present Preliminary Data On Non-Invasive, Cancer Screening Test (GlobeNewswire via Yahoo! Finance)
MUKILTEO, Wash., Feb. 10, 2009 -- CombiMatrix Corporation announced today that preliminary data on its investigational Comprehensive Cancer Array test will be presented publicly for the first time, at Cambridge Healthtech Institute's 16th International Molecular Medicine Tri-Conference being held on February 25-27, 2009, in San Francisco.
(Feb 10, 2009)
Applied Bio pacts with medical institution to study mechanisms of cancer development using SOLiD System (PharmaBiz)
A team of researchers from the Mayo Clinic announced preliminary data that demonstrates the advantages of sequencing-based approaches for associating structural variants with RNA expression profiles to identify potential biomarkers in head and neck cancer.
(Feb 10, 2009)
Washington University Becker Library Makes MetaCore Accessible Throughout the University (PR Newswire via Yahoo! Finance)
GeneGo, Inc., the leading systems biology tools company, announced today that Becker Medical Library at Washington University in St. Louis has licensed MetaCore. The Becker Medical Library Bioinformatics@Becker program is a university wide resource which provides bioinformatics support for researchers and students.
(Feb 10, 2009)
Bioinformatics Tool facilitates proteomic data analysis. (ThomasNet)
ProteoIQ v1.2 provides automated methodology for identifying proteins that possess post-translational modifications. Functionality is specifically designed for researchers using proteomic strategies that involve separations at protein level followed by digestion and separation at peptide level. Also able to identify truncated and degraded proteins, software suits comparative proteomic analyses ...
(Feb 10, 2009)
QuantRx® Announces Additional Patent for its RapidSense® Oral Testing Products (Centre Daily Times)
QuantRx Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that the U.S. Patent and Trademark Office has issued a new patent expanding QuantRx’s oral testing intellectual property suite. This new patent for QuantRx’s oral testing devices expands the Company’s protection, and ...
(Feb 10, 2009)
Research and Markets: Recently Updated Report Examines the Fundamentals of RNAi's Technologies, Markets and Companies (Centre Daily Times)
Research and Markets ( http://www.researchandmarkets. ) has announced the addition of Jain PharmaBiotech's new report " RNAi - Technologies, Markets and Companies " to their offering.
(Feb 10, 2009)
Shades of 1918? New study compares avian flu with a notorious killer from the past (PhysOrg)
In the waning months of the First World War, a lethal virus known as the Spanish flu (influenza A, subtype H1N1), swept the United States, Europe and Asia in three convulsive waves. The year was 1918. The ensuing pandemic claimed up to 100 million victims, most of whom succumbed to severe respiratory complications associated with rapidly progressing pneumonia. Many died within days of the first ...
(Feb 10, 2009)
TRADE NEWS: Agilent Technologies, Protein Discovery Announce Exclusive Agreement for Worldwide Distribution of PPS ... (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif. & KNOXVILLE, Tenn.----Agilent Technologies and Protein Discovery Inc. today announced their distribution agreement for PPS Silent Surfactant, a specialized reagent from Protein Discovery used to prepare biological samples for mass spectrometry analysis.
(Feb 10, 2009)
TRADE NEWS: Agilent Technologies, Protein Discovery Announce Exclusive Agreement for Worldwide Distribution of PPS ... (Centre Daily Times)
Agilent Technologies (NYSE:A) and Protein Discovery Inc. today announced their distribution agreement for PPS Silent Surfactant, a specialized reagent from Protein Discovery used to prepare biological samples for mass spectrometry analysis. The exclusive agreement encompasses aspects of sales, marketing and support for PPS Silent Surfactant.
(Feb 10, 2009)
Biochemists Discover New Biological Mechanism: Transport Factor Divides Protein Synthesis Between Mother And Daughter ... (Science Daily)
Researchers have discovered a new biological mechanism, which ensures that new proteins are created exactly where they are needed in a cell. The research was conducted using the yeast Saccharomyces cerevisiae (baker’s yeast). The mechanism takes effect when cells divide, a process that is asymmetrical in yeast.
(Feb 10, 2009)
Improved Understanding Of How Leukemia Develops: First Genome-Wide Expression Analysis (Medical News Today)
In a collaborative study published Feb. 9, 2009, in the Proceedings of the National Academy of Sciences (PNAS), scientists performed a genome-wide expression analysis comparing highly enriched normal blood stem cells and leukemic stem cells, and identified several new pathways that have a key role in cancer development.
(Feb 10, 2009)
CLC bio launches Science Server, Genomics Server (MacNN)
CLC bio has released a new set of tools for high-performance computing-based analysis of next-generation sequencing data, CLC Science Server and CLC Genomics Server. The software is geared for enterprise use and offers three-tiered functionality including Workbench clients for individual users, a database and a server for completing complex calculations and integrating third-party tools.... ...
(Feb 10, 2009)
OpenHelix Presents UCSC Genome Browser Workshop at African Virtual Conference (PRWeb via Yahoo! News)
OpenHelix Workshop on how to use the UCSC Genome Browser workshop will be presented on February 20th at the first annual African Virtual Conference on Bioinformatics (AfBix'09).
(Feb 10, 2009)
IP Roundup (GenomeWeb News)
Siemens of Munich, Germany, has received US Patent No. 7,488,578, “Method for detecting DNA point mutations (single nucleotide polymorphism (SNP) analysis) and associated arrangement.” The patent claims the following method.
(Feb 10, 2009)
BioArray Briefs (GenomeWeb News)
Several research groups under the auspices of the Association of Biomolecular Resource Facilities are comparing how different microarray platforms stack up when it comes to microRNA analysis.
(Feb 10, 2009)
New Product Watch (GenomeWeb News)
Geospiza this week launched upgraded versions of its GeneSifter Lab Edition and GeneSifter Analysis Edition software.
(Feb 10, 2009)
Washington University to Use GeneGo Software (GenomeWeb News)
NEW YORK (GenomeWeb News) — The Becker Medical Library at Washington University in St. Louis will use GeneGo's data-mining software to give researchers at the school access to pathway information, the company said today.
(Feb 10, 2009)
In Print (GenomeWeb News)
Journal: Bioinformatics . 2009 Jan 1;25(1):48-53. Title: Power enhancement via multivariate outlier testing with gene expression arrays. Authors: A Asare; Z Gao; V Carey; R Wang; V Seyfert-Margolis
(Feb 10, 2009)
Golden Helix to Launch Software This Month to Improve Chip, Sequencing Capacity (GenomeWeb News)
Golden Helix, a 10-year-old Bozeman, Mt.-based bioinformatics firm, will later this month debut the latest version of its software for SNP and copy-number analysis, according to a company official.
(Feb 10, 2009)
‘Strong Demand’ for SNP Chips Helps Illumina Q4 Revenue Surge 49 Percent (GenomeWeb News)
Illumina last week said fourth-quarter revenue swelled 43 percent as a loss in the prior-year period swung to a profit in the current quarter, and Chief Financial Officer Christian Henry said it will "probably" make an acquisition that is on the "smaller rather than the larger side."
(Feb 10, 2009)
Complete Genomics Shows First Human Sequence Data, Plans to Decode Five Genomes for Broad Institute (GenomeWeb News)
Complete Genomics said last week that it has signed up the Broad Institute of Harvard and MIT to test its human genome sequencing services in a pilot project.
(Feb 10, 2009)
Van Andel Research Institute of Michigan and Translational Genomics Research Institute of Arizona Undertake ... (PR Newswire via Yahoo! Finance)
The Van Andel Research Institute and the Translational Genomics Research Institute will forge a strategic alliance that will enable both to maximize their worldwide contributions to science and health.
(Feb 11, 2009)
TGen-Van Andel alliance to bring more scientists to Arizona (The Business Journal of Phoenix)
Phoenix-based Translational Genomics Research Institute is partnering with a similarly young research organization in Michigan, giving TGen a financial boost that will allow the nonprofit to recruit more scientists.
(Feb 11, 2009)
Phoenix-based TGen forms lucrative alliance (The Arizona Republic)
The research organization has struck a pact with a Michigan research institute that calls for the two groups to share resources and leadership.
(Feb 11, 2009)
Comparative Genomics Reveals Molecular Evolution Of Q Fever Pathogen (Science Daily)
Scientists have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others.
(Feb 11, 2009)
First Genome-wide Expression Analysis Yields Better Understanding Of How Leukemia Develops (Science Daily)
Scientists have performed a genome-wide expression analysis comparing highly enriched normal blood stem cells and leukemic stem cells, and identified several new pathways that have a key role in cancer development.
(Feb 11, 2009)
Camouflaging Of Viral DNA Could Be Crucial Step In Progression Of Cancers (Medical News Today)
An estimated 15% of cancer cases can be linked to a viral infection, however the biological changes that cause some asymptomatic carriers of a virus to develop full-blown tumors are not well understood.
(Feb 11, 2009)
Promega And Celsis In Vitro Technologies To Offer More Reliable Solutions For ADME/Tox Testing In Primary Hepatocytes (Medical News Today)
Promega Corp. and Baltimore, Md.-based Celsis In Vitro Technologies (Celsis IVT) will take the trial and guess work out of ADME/Tox testing in primary hepatocytes. Promega will co-market their bioluminescent ADME-Tox assays with Celsis' extensive line of high quality cryopreserved plateable hepatocytes.
(Feb 11, 2009)
CLC bio launches next generation sequencing data analysis (PharmaBiz)
CLC bio just launched their new enterprise level product line, consisting of CLC Science Server and CLC Genomics Server.
(Feb 11, 2009)
Role Of Prostate Specific Membrane Antigen And Pepsinogen C Tissue Expression As An Adjunctive Method To Prostate ... (Medical News Today)
UroToday.com - In the February 2009 issue of the Journal of Urology, Dr. Alberto Antunes and colleagues from Sao Paulo, Brazil reported on the use of a gene microarray to identify an expression profile that may improve the ability to diagnose prostate cancer (CaP). The study included tissue from 50 patients who underwent surgery between 1997 and 2000.
(Feb 11, 2009)
Van Andel Research Institute and TGen undertake alliance to promote science and health (EurekAlert!)
( The Translational Genomics Research Institute ) The Van Andel Research Institute and the Translational Genomics Research Institute will forge a strategic alliance that will enable both to maximize their worldwide contributions to science and health.
(Feb 11, 2009)
Research and Markets: Genomics in Drug Discovery and Development Introduces Readers to the Biomarker, Pharmacogenomic, ... (Business Wire via Yahoo! Finance)
DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Genomics in Drug Discovery and Development" to their offering.
(Feb 11, 2009)
Aushon BioSystems Appoints Joseph Blanchard Chief Operating Officer (Business Wire via Yahoo! Finance)
BILLERICA, Mass.----Aushon BioSystems, Inc, the leading provider of advanced microarray instrumentation and laboratory services for biomarker analysis, has appointed Joseph Blanchard as the company's Chief Operating Officer.
(Feb 11, 2009)
Genome-wide leukemia analysis completed (UPI)
ROCHESTER, N.Y., Feb. 11 (UPI) -- U.S. medical researchers say they have completed the first genome-wide expression analysis involving leukemia.
(Feb 11, 2009)
Research and Markets: Genomics in Drug Discovery and Development Introduces Readers to the Biomarker, Pharmacogenomic, ... (Centre Daily Times)
Research and Markets ( http://www.researchandmarkets. ) has announced the addition of John Wiley and Sons Ltd's new report " Genomics in Drug Discovery and Development " to their offering.
(Feb 11, 2009)
Aushon BioSystems Appoints Joseph Blanchard Chief Operating Officer (Centre Daily Times)
Aushon BioSystems, Inc, the leading provider of advanced microarray instrumentation and laboratory services for biomarker analysis, has appointed Joseph Blanchard as the company’s Chief Operating Officer. Mr. Blanchard brings more than 20 years of leadership experience in the global life sciences market to his new role, including senior level positions in corporate development, operations ...
(Feb 11, 2009)
|
